Diagnostic Histopathology
Volume 15, Issue 10 , Pages 470-477 , October 2009

Pathology of minimal metastatic disease in sentinel lymph nodes in breast cancer

References 

  1. Fisher B, Bauer M, Wickerham L. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer. 1983;52:1551–1557
  2. Colleoni M, Rotmensz N, Peruzzotti G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005;23:1379–1389
  3. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–466
  4. Krag D, Weaver DL, Ashikaga T, et al. The sentinel node in breast cancer. N Engl J Med. 1998;339:941–946
  5. Giuliano AE, Jones RC, Brennan MB, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345–2350
  6. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864–1867
  7. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368–373
  8. Reitsamer R, Peintinger F, Prokop E, et al. 200 Sentinel lymph node biopsies without axillary lymph node dissection - no axillary recurrences after a 3-year follow-up. Br J Cancer. 2004;90:1551–1554
  9. Schwartz GF, Giuliano AE, Veronesi U, et al. Proceedings of the census conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;33:579–589
  10. Veronesi U, Paganelli G, Viale G. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–553
  11. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;180:700–704
  12. Turner RR, Ollila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997;226:271–276
  13. Weaver DL, Krag D, Ashikaga T, et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma. Cancer. 2000;88:1099–1107
  14. AJCC cancer staging handbook. From the AJCC cancer staging manual. New York: Springer; 2002;
  15. Sobin LH, Wittekind C. TNM classification of malignant tumors. New York: Wiley-Liss; 2002;
  16. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumour cells. Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer. 2003;98:2740–2741
  17. Weaver DL. Sentinel lymph nodes and breast carcinoma: Which micrometastases are clinically significant?. Am J Surg Pathol. 2003;27:842–845
  18. Hermanek P, Hutter RVP, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86:2668–2673
  19. Querzoli P, Pedriali M, Rinaldi R, et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res. 2006;12:6696–6701
  20. Cserni G, Amendoeira I, Apostolikas N, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol. 2003;57:695–701
  21. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumour cells. Cancer. 2004;103:358–367
  22. Roberts CA, Beitsch P, Litz CE, et al. Interpretive disparity among pathologists in breast sentinel lymoh node evaluation. Am J Surg. 2003;186:324–329
  23. Cserni , Bianchi S, Vezzosi V, et al. Variations in sentinel node isolated tumour cells/micrometastases and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer. 2008;44:2185–2191
  24. Turner RR, Weaver DL, Cserni G, et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol. 2008;26:258–263
  25. Connolly JL. Changes and problematic areas in interpretation of the AJCC Cancer Staging Manual, 6th edn, for breast cancer. Arch Pathol Lab Med. 2006;130:287–291
  26. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?. Ann Surg. 1999;229:536–541
  27. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?. J Clin Oncol. 1999;17:1726
  28. Teng S, Dupont E, McCann C, et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?. Am Surg. 2000;66:574–578
  29. Rahusen FD, Torrenga H, van Diest PJ, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg. 2001;136:1059–1063
  30. Cserni G, Gregori D, Merletti F, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg. 2004;91:1245–1252
  31. Rutledge H, Davis J, Chiu R, et al. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol. 2005;18:762–768
  32. Viale G, Maiorano E, Pruneri G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005;241:319–325
  33. van Deurzen C, de Boer M, Monninkhof EM, et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst. 2008;100:1574–1580
  34. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007;14:3378–3384
  35. De Mascarel I, MacGrogan G, Debled M, et al. Distinction between isolated tumor cells and micrometastases in breast cancer. Is it reliable and useful?. Cancer. 2008;112:1672–1678
  36. Degnim AC, Griffith KA, Sabel MS, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. A metaanalysis. Cancer. 2003;98:2307–2315
  37. Fitzgibbons PL, Connolly JL, Page DL. Updated protocol for the examination of specimens from patients with carcinomas of the breast. Arch Pathol Lab Med. 2000;124:1026–1032
  38. NHSBSP Guidelines for Pathology Reporting in Breast Disease Pub. No. 58 Version 2. 2005.
  39. Perry N, Broeders M, de Wolf C, et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Luxembourg: European Communities; 2006;
  40. Cserni G. A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol. 2004;57:467–471
  41. Cserni G. Histopathologic examination of the sentinel lymph nodes. Breast J. 2006;12:S152–S156
  42. Cserni G. Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol. 2000;113:345–350
  43. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol. 2002;55:926–931
  44. Cserni G, Amendoeira I, Apostolikas N, et al. Pathologic work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer. 2003;39:1654–1667
  45. Torrenga H, Rahusen FD, Meijer S, et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol. 2001;54:550–552
  46. Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol. 2008;26:3338–3345
  47. Martin Martinez MD, Veys I, Majjaj S, et al. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. Eur J Surg Oncol. 2009;35:387–392
  48. Veys I, Durbecq V, Majjaj S, et al. Eighteen months clinical experience with the GeneSearch breast lymph node aassay. Am J Surg. 2009 Feb 26;[Epub ahead of print]
  49. Viale G, Dell'Orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathological examination and a real-time reverse-transcription polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008;247:136–142
  50. Schem C, Maass N, Bauerschlag DO, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch. 2009;454:203–210
  51. Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer. 2008;122:2562–2567
  52. Tamaki Y, Akiyama F, Iwase T, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res. 2009;15:2879–2884
  53. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res. 2007;13:4807–4816
  54. Daniele L, Annaratone L, Allia E, et al. Technical limits of comparison of step-sectioning, immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn fixed tissue. J Cell Mol Med. 2008 Jul 30;[Epub ahead of print]

PII: S1756-2317(09)00143-1

doi: 10.1016/j.mpdhp.2009.07.005

Diagnostic Histopathology
Volume 15, Issue 10 , Pages 470-477 , October 2009

Article Tools

* Image Usage & Resolution